Case Consult: 48-Year-old Man With Type 2 Diabetes

Access Activity

Overview / Abstract:

Target Audience
This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs.

Program Overview
This case consult will examine the differences in characteristics and clinical profiles of new and emerging nonstatin LDL-C-lowering agents.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Identify patients taking statins who may benefit from additional low-density lipoprotein cholesterol (LDL-C)–lowering interventions
Develop evidence-based treatment plans for at-risk patients who require additional lowering of LDL-C levels beyond statin therapy, considering patient preferences and accessibility/coverage
Discuss strategies to the knowledge, skills, or performance of the healthcare team


Jan 28, 2023


Physician CME



Credits / Hours




Presenters / Authors / Faculty

Presenting Faculty
Daniel E. Soffer, MD, FNLA

Michelle L. O’Donoghue, MD, MPH
Joseph J. Saseen, PharmD, CLS, FNLA

Sponsors / Supporters / Grant Providers

Novartis Pharmaceuticals Corporation

Keywords / Search Terms

Relias LLC Relias, Free CME, Type 2 Diabetes, Diabetes Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map